Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery

A. M. Morales-Burgos*, E. Carvajal-Millan, N. Sotelo-Cruz, A. Rascón-Chu, J. Lizardi-Mendoza, Y. L. López-Franco, Marcel Martínez-Porchas, R. Canett-Romero

*Autor correspondiente de este trabajo

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

4 Citas (Scopus)

Resumen

In vivo evaluation of arabinoxylans (AX) microspheres showed to protect insulin from degradation in the upper gastrointestinal tract and carrier insulin to colon. Insulin-loaded AX microspheres (50 UI/kg) decreased blood glucose level by 39% in diabetic rats with a maximum effect at 18 h post-administration, indicating that insulin remains bioactive. The continuous administration (4 days) of insulin-loaded AX microspheres improved the polyuria and increased the production of short-chain fatty acids, as well as Bifidobacterium and Bacteroides in diabetic rats compared to untreated diabetic rats. AX microspheres are a potential microbiota-activated carrier for colon-specific drug delivery and could be useful as a complementary treatment for diabetes.

Idioma originalInglés
Páginas (desde-hasta)16-22
Número de páginas7
PublicaciónEuropean Journal of Pharmaceutics and Biopharmaceutics
Volumen163
DOI
EstadoPublicada - jun 2021

Nota bibliográfica

Publisher Copyright:
© 2021 Elsevier B.V.

Huella

Profundice en los temas de investigación de 'Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery'. En conjunto forman una huella única.

Citar esto